TFPI Monoclonal Antibody (OTI4H9), TrueMAB™, OriGene

Catalog No.	Quantity
50-168-0949	100 μL

Catalog No. 50-168-0949 Supplier OriGene Supplier No. TA806052

Description

Mouse Monoclonal Antibody

Tissue factor pathway inhibitor (TFPI), also known as lipoprotein-associated coagulation inhibitor, is a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. TFPI is glycosylated and predomitly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. TFPI inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop.

Specifications

• Antigen: TFPI
• Applications: Immunohistochemistry (Paraffin), Western Blot
• Classification: Monoclonal
• Clone: OTI4H9
• Conjugate: Unconjugated
• Formulation: PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
• Gene: TFPI
• Gene Accession No.: P10646
• Gene Alias: EPI, LACI, TFI, TFPI1
• Gene Symbols: TFPI
• Host Species: Mouse
• Immunogen: Human recombit protein fragment corresponding to amino acids 29-304 of human TFPI produced in E.coli.
• Purification Method: Affinity Chromatography
• Quantity: 100 μL
• Regulatory Status: RUO
• Primary or Secondary: Primary
• Gene ID (Entrez): 7035
• Target Species: Human
• Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
• Product Type: Antibody
• Form: Liquid
• Isotype: IgG2a